AKT1 and lung carcinoma: Furthermore, in lung cancer, BAG4 has been implicated in promoting proliferation, invasion, metastasis and drug resistance, functioning within the PI3K/PDK1/AKT and RAF/MEK/ERK signaling pathways [12].